Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study

Name: Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study
License: Public Domain

The First Hospital of Jilin University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 451473
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.